Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz) for ...
Background Anti-C1q autoantibodies can disrupt normal complement function, contributing to the formation of pathogenic immune ...
The Indiana Fever have advanced to the WNBA semifinals by beating the Atlanta Dream 2-1 in their best-of-3 first-round series. The Fever won Game 3 87-85 in Atlanta. The Fever will play the Las Vegas ...
Johnson & Johnson (NYSE: JNJ) today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVY™ ...
Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...
BMS Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus ...
Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback